Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma

Andrew X. Zhu; Ari David Baron; Peter Malfertheiner; Masatoshi Kudo; Seiji Kawazoe; Denis Pezet; Florian Weißinger; Giovanni Brandi; Carlo Barone; Takuji Okusaka; Yoshiyuki Wada; Joon Oh Park; Baek‐Yeol Ryoo; Y. Choi; Hyun Cheol Chung; Chung‐Pin Li; Chia-Jui Yen; Kuan‐Der Lee; Shao-Chun Chang; Ling Yang; Paolo Abada; Ian Chau

doi:10.1001/jamaoncol.2016.4115

Related publications

Article2023

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma

Shukui Qin, Masatoshi Kudo, Tim Meyer, Yuxian Bai, Yabing Guo, Zhiqiang Meng, Taroh Satoh, Donatella Marino, Éric Assenat, Songzi Li, Yaxi Chen, Frédéric Boisserie, Ramil Abdrashitov, Richard S. Finn, Arndt Vogel, Andrew X. Zhu

Article2015

Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Analysis of REACH pts by Child-Pugh (CP) score.

Andrew X. Zhu, Ari David Baron, Peter Malfertheiner, Masatoshi Kudo, Seiji Kawazoe, Denis Pezet, Florian Weißinger, Giovanni Brandi, Carlo Barone, Takuji Okusaka, Yoshiyuki Wada, Joon Oh Park, Baek‐Yeol Ryoo, Y. Choi, Hyun Cheol Chung, Chung‐Pin Li, Chia‐Jui Yen, Kuan‐Der Lee, Ling Yang, Ian Chau

Article2016

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial

Masatoshi Kudo, Etsuro Hatano, Shinichi Ohkawa, Hirofumi Fujii, Akihide Masumoto, Junji Furuse, Yoshiyuki Wada, Hiroshi Ishii, Shuntaro Obi, Shuichi Kaneko, Seiji Kawazoe, Osamu Yokosuka, Masafumi Ikeda, Katsuaki Ukai, Sojiro Morita, Akihito Tsuji, Toshihiro Kudo, Mitsuo Shimada, Yukio Osaki, Ryosuke Tateishi, Gen Sugiyama, Paolo Abada, Ling Yang,

Article2016

Ramucirumab as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Analysis of Reach Patients by Albumin-Bilirubin (ALBI) Grade

J.-F. Blanc, Stephen L. Chan, J.O. Park, Baek‐Yeol Ryoo, Chung‐Jen Yen, Masatoshi Kudo, Rtp Poon, Davide Pastorelli, Ari David Baron, Tatiana Pfiffer, Takuji Okusaka, Kateřina Kubáčková, Jörg Trojan, Javier Sastre, Ian Chau, Paolo Abada, Samuel Chang, Ling Yang, Alice Zhu

Article2020

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Thomas Yau, Yoon‐Koo Kang, Tae‐You Kim, Anthony B. El-Khoueiry, Armando Santoro, Bruno Sangro, Ignacio Melero, Masatoshi Kudo, Ming-Mo Hou, Ana Matilla, Francesco Tovoli, Jennifer J. Knox, Aiwu Ruth He, Bassel F. El‐Rayes, Mirelis Acosta-Rivera, Ho-Yeong Lim, Jaclyn Neely, Yun Shen, Tami Wisniewski, Jeffrey Anderson, Chiun Hsu